Sign In
Buy KFS
$10.73
+0 (+0%)
At Close: Jun 03, 2026
Celyad Oncology's (CYAD) CEO Filippo Petti on First Half 2020 Results - Earnings Call Transcript
02:07pm, Saturday, 08'th Aug 2020
Celyad Oncology SA (NASDAQ:CYAD) First Half 2020 Earnings Conference Call August 07, 2020 8:00 AM ET Company Participants Filippo Petti – Chief Executive Officer David Gilham – Chief Scientific Of
Nucor Excels On Costs And Is Using Its Efficiency As A Strategic Weapon (NYSE:NUE)
09:38pm, Friday, 07'th Aug 2020
Nucor had an impressive EBITDA beat, as the company did a good job of reducing costs and saw a comparatively healthier demand for higher-value products used in end-markets like construction.
Editas Medicine, Inc. (EDIT) Q2 2020 Earnings Call Transcript | The Motley Fool
07:31pm, Friday, 07'th Aug 2020
EDIT earnings call for the period ending June 30, 2020.
Kim Jong-un sends nuclear warning to US with promotion of military hardliner - expert
05:23pm, Friday, 07'th Aug 2020
KIM JONG-UN's apparent promotion of military hardliner sends a message to the United States in advance of November's Presidential election that the Hermit State must now be taken seriously as a nuclea
Integrated Waste : Environmental, Social and Governance Report 2020 | MarketScreener
04:02am, Thursday, 06'th Aug 2020StratEdge White Paper, “Eutectic Die Attach Optimizes High Power GaN Devices,” is Now Available
12:00am, Thursday, 06'th Aug 2020
StratEdge announces a new white paper is available which discusses assembly methods to optimize GaN device’s efficiency, performance, and reliability.
Stunned by gold's record rise? There's more to come, analysts say
12:00am, Wednesday, 05'th Aug 2020
Stunned by gold's record rise? There's more to come, analysts say
Provention Bio: Undervalued And Overlooked Biotech Company - Diabetes Is Not Going Away Anytime Soon (NASDAQ:PRVB)
02:10pm, Tuesday, 04'th Aug 2020
Teplizumab's At-Risk PHASE II trial showed promising results in significantly delaying the onset of T1D in pre-symptomatic patients by a median of three years relative to placebo.
IPO Update: Freeline Therapeutics Proposes Terms For U.S. IPO (Pending:FRLN)
05:44pm, Monday, 03'rd Aug 2020
Freeline Therapeutics Holdings plc has filed to raise $125 million in a U.S. IPO.
The People’s Liberation Army is strong. But it has four weaknesses
12:48pm, Friday, 31'st Jul 2020
It hasn’t fought since 1979; it has been corrupt; it lacks skilled personnel; and it has financial issues
5 Value Stocks In The Basic Materials Sector
12:00am, Friday, 31'st Jul 2020
What are Value Stocks?
A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be...
Can BT Share Price Regain Confidence After Recent Lows?
12:00am, Thursday, 30'th Jul 2020
Shares Analysis by CMC Markets covering: BT Group PLC. Read CMC Markets's latest article on Investing.com UK.
LGM Pharma Acquires Pharmaceutical Development and Manufacturing Unit of Nexgen Pharma
12:00am, Monday, 27'th Jul 2020
LGM Pharma announced that it has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc.
CoinMarketCap shills Binance yet again - CoinGeek
07:00am, Sunday, 26'th Jul 2020
The digital currency data platform recently added a “top DeFi tokens by Market Cap” page—an addition that did not come without conflict.
Upcoming Indices Dividend Drop Points
12:00am, Sunday, 26'th Jul 2020
Shares Analysis by CMC Markets covering: Vodafone Group PLC. Read CMC Markets's latest article on Investing.com UK.
